The global network of Eurofins Central Laboratory companies is dedicated to providing end-to-end clinical trial laboratory testing solutions. With 4 standardised, wholly-owned testing facilities in the US, the Netherlands, Singapore, and China, we provide CAP/CLIA certified analytical services in both a GCP and GCLP environment. This allows us to combine safety & efficacy testing with biomarker services embedded within one laboratory, enabling cost efficiencies into sponsor study budgets, and safeguarding specimen integrity. Complementing the four central laboratory facilities, our fifth CAP-accredited pathology laboratory in the United States serves as an extension of the global laboratory network, further enhancing its specialised testing capabilities.
As a world‑leading provider of global central laboratory solutions, Eurofins Central Laboratory is fully dedicated to supporting the success of complex clinical trials. Our organisation is built around the needs of our customers, delivering high‑quality clinical data with complete transparency and scientific rigor.
Our global footprint — comprising five wholly owned, CAP‑accredited laboratories in the United States, Europe, Singapore, and China — allows us to support patient access across all major regions. This infrastructure, combined with in‑country testing where appropriate, strengthens sample integrity, shortens turnaround times, and ensures consistent service standards. Through harmonised methods and unified data delivery, we enable true global study oversight while still providing tailored support for region‑specific needs.